📊 Analyst Consensus & Targets
- Analyst Rating: Buy
- Price Target: $325.8837
- Sector: Healthcare – Drug Manufacturers – General
💡 The Growth Thesis
Buy Consensus: Amgen Inc. Analysts project a -0.4% potential upside. Currently trading at a Forward P/E of 14.920107.